P-38: Comparison of Oxidative Stress and Antioxidative Status in non Obese Women with and without Polycystic Ovary Syndrome
Authors
Abstract:
This article doesn't have abstract
similar resources
P-182: The Comparison of Clinical and Laboratory Characteristics in Obese and Normal Weight Women with Polycystic Ovary Syndrome
Background: The main characteristic of polycystic ovary syndrome (PCOS) is oligomenorrhea with clinical and biochemical signs of hyperandrogenism(HA) and the phenotypic spectrum of PCOS is very broad. There are very limited studies about the features of patients with PCOS in Iran. The purpose of this study is to compare the clinical and laboratory characteristics of PCOS between the overweight ...
full textP-223: Comparing Dietary Intake in Women with and without Polycystic Ovary Syndrome
Background: Adequate nutritional status is a critical determinant of the onset and maintenance of normal reproductive function. More than 50% of women with PCOS are obese and central obesity plays a central role in the pathogenesis of PCOS by generating an insulin- resistant state, It has been proposed that recurrent hypoglycaemia due to hyperinsulinaemia could lead to decreased post-prandial s...
full textThe comparison of dietary intake of macronutrients in polycystic ovary syndrome with and without metabolic syndrome
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive age women. The prevalence of PCOS among Iranian women is 14.6% based on the Rotterdam definition. PCOS can increase the risk of chronic metabolic complications. Metabolic syndrome (MetS) is one of the most important of them. Insulin resistance is fundamental in PCOS and MetS pathophysiology. MetS ...
full textP-205: Effects of Aerobic Exercise on Plasma Lipoproteins in Overweight and Obese Women with Polycystic Ovary Syndrome
Background: Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine disorders. Obesity and anovulation in the women affected by this syndrome leads to a type of obesity that is followed by cardiovascular disease, hypertention and cholesterol and lipoprotein improper profiles. Changing the life style, e.g. increasing physical activities is the first approach in controlling PCOS Ma...
full textP-220: A Two Purpose Use of Orlistat in Obese Women with Polycystic Ovary Syndrome: Weight Loss and Androgen Reduction
Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in young women. PCOS affects 6% and 8% of women in reproductive age. Hyperandrogenism is the hallmark of PCOS. Clinically, it is possible to observe hirsutism, acne, androgenic alopecia, and signs of virilization. Laboratory examination reveals increased androgen levels. Excessive androgen has an important r...
full textDifferential Expression of Circulating miRNA-103 in Women with and without Polycystic Ovary Syndrome
Background and Aims: Polycystic ovary syndrome (PCOS) has a largely unknown etiology and is a common heterogeneous endocrine disorder in women of reproductive age, characterized by polycystic ovaries, hyperandrogenism, insulin resistance, and chronic anovulation. MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miR...
full textMy Resources
Journal title
volume 5 issue Supplement Issue
pages -
publication date 2011-09-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023